Document is current
Any future updates will be listed below
-
Authors
Schragel, Felix https://orcid.org/0009-0006-7019-8325
Matousek, Melanie
Resl, Christoph
Kreye, Gudrun
Le, Nguyen-Son
Errhalt, Peter
Georg, Petra
Hackner, Klaus
-
Funding
Funding for this research was provided by:
Karl Landsteiner Privatuniversität für Gesundheitswissenschaften
- License Information
-
More Information
Article History
Received: 6 September 2024
Accepted: 6 January 2025
First Online: 13 February 2025
Declarations
:
: F. Schragel declares that he received honoraria from Roche, Menarini and MSD. K. Hackner declares that he received honoraria from AstraZeneca, Roche, Amgen, Novartis, Boehringer Ingelheim, and Excentia and had consulting or advisory roles for Amgen, Novartis, and Boehringer Ingelheim. M. Matousek, C. Resl, G. Kreye, N.-S. Le, P. Errhalt and P. Georg declare that they have no competing interests.
: The study was approved by the Institutional Review Board and the Ethics Committee of Lower Austria (GS4-EK-4/798-2022) and was conducted according to the Declaration of Helsinki. Patient consent was waived due to the retrospective nature of this study.
